Events & Training for February 2015

Biotech and Money London

03 February 2015 - 04 February 2015

Where Bioscience Meets Money - Investors Uncover Innovation - Pharma Seek Partners Biotech and Money London is a two-day congress providing the education, strategies and solutions you need to enable more effective funding, investment, business planning and partnering within your business.

etc.venues 155 Bishopsgate Liverpool St. London, UK

Advances & Progress in Drug Design

16 February 2015 - 17 February 2015

As science and technology is advancing, drug designing has moved from traditional methods to advanced methods like computer aided drug designing and computational techniques. This informative event will focus on the recent developments and growth drivers in drug design. High profile scientists from pharma companies and biotech organisations will be speaking about structure based drug designing, fragment based drug designing, computer based drug designing, pharmacokinetics, polypharmacology and metabolism in drug designing.

Marriott Regents Park Hotel, London, UK

6th annual conference on RNA Therapeutics

16 February 2015 - 17 February 2015

RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies to maximise return on investment. The cutting edge event will ask questions such as: What are the current opportunities, obstacles and solutions for developing effective RNAi based drugs? What makes CRISPR-Cas special and how can be used as a role model for personalised medicine? Why use a patent to protect a biotech innovation? How do we unlock the potential with locked nucleic acid? How does the next generation of ASOs demonstrate robust target knock down in multiple preclinical cancer models? Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing the latest advancements and programmes, CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more!

Marriott Hotel, Regents Park, London, UK

Protease Inhibitors in Drug Discovery Conference

26 February 2015 - 27 February 2015

This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, deubiquitinating enzymes, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions. Sessions for the meeting include: I. Targeting Proteases in the Cardiovascular System II. Protease Inibitors in Infection and Immunity III. Protease Inhibitors in Cancer Therapy IV. Membrane-Associated Systems V. Deubiquitinating Enzymes Inhibitors VI. Non-Active Site Inhibition of Proteases VII. Advances in Protease Targeted Therapies

Paradise Point Resort & Spa, San Diego, CA, USA

Catalyses in Drug Discovery Summit

26 February 2015 - 27 February 2015

We are excited to announce the inaugural Catalyses in Drug Discovery Summit, which will take place February 26 - 27, 2015 in San Diego, CA. This summit will feature the following three conferences, which will happen in parallel: Enzymes in Drug Discovery Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes. Ubiquitin Research & Drug Discovery This meeting will discuss how recent structural insights into ubiquitin have opened the door to other possibilities in drug discovery. Researchers will discuss hot topics such as phosphorylation of ubiquitin, particularly in Parkinson's Disease, DUBs as drug targets, and many more. Protease Inhibitors in Drug Discovery Proteolytic enzymes have always been on the forefront of cancer research, though scientists in the field are still working to overcome the challenge of specificity in drug design. This meeting will discuss new mechanisms of actions for better specificity and cover hot topics such as exosites, membrane-associated systems, and more.

Paradise Point Resort & Spa, San Diego, CA, USA